Surgifort is the first FDA-approved human milk-based fortifier specifically designed for term infants recovering from ...

Keytruda demonstrated a statistically significant and clinically meaningful improvement in event-free survival and major ...

Daniel Vitt, CEO, Immunic Therapeutics, discusses how IMU-856 could support the challenges of gluten-free diets and cross-contamination risks for celiac disease.

Aspargo Labs uses a proprietary technology platform to reformulate oral medication to liquid doses. CEO and chairman Michael ...